Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era: Correspondence to editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

키워드

참고문헌 (12)

1. Huang DQ, "Hepatocellular carcinoma surveillance-utilization, barriers and the impact of changing aetiology", Nat Rev Gastroenterol Hepatol, 20, pp.797~809 (2023)
2. Huang CF, "Chronic hepatitis C related steatotic liver disease is more than"Miscellaneous Steatotic Liver Disease"", Clin Gastroenterol Hepatol, 22, pp.2137~2139 (2024)
3. Yen YH, "The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients", Liver Int, 38, pp.1064~1073 (2018)
4. Sano T, "Metabolic management after sustained virologic response in elderly patients with hepatitis C virus : A multicenter study", Hepatol Res, 54, pp.326~335 (2024)
5. Yeh ML, "Long-term outcome of liver complications in patients with chronic HBV", HCV co-infection after antiviral therapy : a realworld nationwide study on Taiwanese Chronic Hepatitis C Cohort(T-COACH), 2021, pp.15, 1109~1121
6. Tsai PC, "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy", Clin Mol Hepatol, 30, pp.468~486 (2024)
7. Perez S, "Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals", PLoS Genet, 15, pp.e1008181~ (2019)
8. Hamdane N, "HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response", Gastroenterology, 156, pp.2313~2329 (2019)
9. Jühling F, "Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma", Gut, 70, pp.157~169 (2021)
10. Hlady RA, "Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance", Hepatology, 75, pp.983~996 (2022)
11. Sugimachi K, "Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma", JGH Open, 6, pp.854~863 (2022)
12. Imamura T, "Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation", Cancer Med, 11, pp.1769~1786 (2022)

관련 논문AI추천